Ultraview corporation:1294591 [17-052299]
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201700440P
- Awardee
-
Ultraview Corporation UEI QKZRCMNWCM37
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $9,995
Award facts
- Contract value 100% obligated
- $9,995.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Ultraview Corporation valued at $9,995.00 on July 27, 2017. Work is performed at Bethesda, Maryland. The order carries a firm fixed price and ultimate completion date of August 20, 2017. No set-aside was used.
Quick answers
Who was awarded contract HHSN261201700440P?
HHSN261201700440P was awarded to Ultraview Corporation by National Cancer Institute (National Institutes of Health) on July 27, 2017.
How much is contract HHSN261201700440P worth?
The government has obligated $9,995 on HHSN261201700440P.
Was contract HHSN261201700440P competed?
The extent of competition for HHSN261201700440P was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award